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NANOBEADS FORMATION FOR ANTICANCER DRUG RELEASE 
CONTROLLED BY ELECTROSPINNING 
 
 
ABSTRACT 
 
 
Anticancer drug nowadays have become one of the most important industry in 
the world. In order to improve drug delivery, the used of nanoparticles is the main 
purpose for this research study. The objectives for this study are to investigate the 
morphology of nanoparticles produced based on different molecular weight of and 
concentration of Polyethylene Oxide (PEO). In this research, a very high molecular 
weight (MR) PEO is used as the core polymer. Two types of PEO used are with 400 000 
MW and 900 000 MW. There are two types of solvents used that are distilled water and 
ethanol. Whey protein is used because it containing Cysteine, one of the sulphur-
containing amino acid and has same properties as anticancer drug. Henceforth, whey 
protein is used because it is easily to purchase and cheaper. PEO acts as shell that 
encapsulated the drug. There are two main processes for the nanoparticles preparation 
that are solution preparation and electrospinning. Four types of solution are prepared; 
PEO with water, PEO with Ethanol, PEO with protein, and PEO with protein and 
ethanol. All samples are prepared till 10 mL and 20 mL and then go through the 
electrospinning about 5 hours. After electrospinnig the samples will be analyzed under 
Field Emission Scanning Electron Microscopy (FESEM) to observe the morphology of 
nanoparticles and Energy Dispersive X- Ray (EDX) for sulphur determination. The 
resulted obtained showed the lower the viscosity, the more the formation of nanobeads. 
Lower molecular weight also affects the nanobeads formation as lower molecular weight 
is more beads than higher molecular weight. 
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NANOBEADS FORMATION FOR ANTICANCER DRUG RELEASE 
CONTROLLED BY ELECTROSPINNING 
 
 
ABSTRAK 
 
 
Ubat antikanser pada masa kini telah menjadi salah satu industri yang paling 
penting di dunia. Dalam usaha untuk meningkatkan penyampaian ubat, penggunaan 
nanopartikel menjadi tujuan utama kajian ini dibuat. Objektif kajian ini adalah untuk 
menyiasat morfologi nanopartikel yang dihasilkan berdasarkan berat molekul yang 
berlainan dan kepekatan Oksida Polyethylene (PEO). Dalam kajian ini, berat molekul 
yang sangat tinggi (MR) PEO digunakan sebagai polimer teras. Dua jenis PEO 
digunakan dengan 400 000 MW dan 900 000 MW. Terdapat dua jenis pelarut yang 
digunakan iaitu air suling dan etanol. Whey protein digunakan kerana ia mengandungi 
Cysteine, salah satu daripada asid amino yang mengandungi sulfur dan mempunyai ciri-
ciri yang sama sebagai ubat antikanser. Seterusnya, protein whey digunakan kerana ia 
adalah mudah dibeli dan murah. Terdapat dua proses utama untuk penyediaan 
nanopartikel iaitu penyediaan larutan dan electrospinning. Empat jenis larutan 
disediakan; PEO dengan air, PEO dengan Etanol, PEO dengan protein, dan PEO dengan 
protein dan etanol. Semua sampel disediakan antara 10 mL hingga 20 mL dan kemudian 
akan melalui electrospinning kira-kira 5 jam. Selepas electrospinnig, sampel akan 
dianalisis di bawah Pelepasan Lapang Mengimbas Mikroskopi Elektron (FESEM) untuk 
melihat morfologi nanopartikel dan Sebaran Tenaga X-Ray (EDX) bagi menentukan 
sulfur. Keputusan yang diperolehi menunjukkan lebih rendah kelikatan, lebih banyak 
pembentukan nanopartikel. Berat molekul yang lebih rendah juga memberi kesan 
kepada pembentukan nanopartikel iaitu apabila berat molekul yang rendah adalah 
menghasilkan lebih banyak manik daripada berat molekul yang lebih tinggi. 
 
 
vii 
 
 
TABLE OF CONTENT 
 
TITLE PAGE 
DECLARATION OF SUPERVISOR  
DECLARATION OF STUDENT ii 
ACKNOWLEDGEMENT iv 
ABSTRACT  v 
ABSTRAK vi 
LIST OF TABLES ix 
LIST OF FIGURES  x 
LIST OF ABBREVIATIONS 
LIST OF SYMBOLS 
xii 
xiii 
 
CHAPTER 1 INTRODUCTION  
1.1 Background of Study 1 
1.2 Problem Statement 3 
1.3 Objectives of Research 4 
1.4 Scopes of Research 4 
1.5 Rational Of Significant Study 5 
  
CHAPTER 2 LITERATURE REVIEW  
2.1 Electrospinning       6 
2.1.1    History of Electrospinning  6         6    
2.1.2    Electrospinning Process 8 
2.2 Drug Delivery Technology 11 
2.3 Nanoparticles in Drug Delivery 12 
2..3.1   Therapeutics 14 
2.4 Polyethylene as Core Solution 15 
  
viii 
 
CHAPTER 3 METHODOLOGY 
3.1 Materials 17 
3.2 Core Solutions Preparation 17 
3.3 Measurement of Solution Viscosity 20 
3.4 Electrospinning of Polymer 20 
3.5 Field Emission Scanning Electron Microscope (FE-SEM) 22 
3.6 Energy Dispersive X-Ray (EDX) 29 
3.7 The summary of workflow 22 
  
CHAPTER 4 RESULTS & DISCUSSIONS   
4.1 Viscosity Measurement 23 
4.2 Morphology Study of Electrospun Nanobeads (FESEM)  
4.2.1    Effect of Different Molecular Weight on The Surface 25 
            Morphology of Nanobeads  
4.2.2    Effect of Viscosity on Nanobeads Formation 28 
4.3       FE-SEM EDX Analysis  
4.3.1    1.5% 400 000 MW PEO + Protein 34 
4.3.2    1.5% 400 000 MW PEO + Ethanol + Protein 35 
4.3.3    3.0% 400 000 MW PEO + Protein 36 
  
CHAPTER 5 CONCLUSION & RECOMMENDATION  
5.1 Conclusion 38 
5.2 Recommendation 39 
  
REFERENCES 40 
  
APPENDICES  
Appendix A 43 
Appendix B 46 
Appendix C 47 
 
ix 
 
LIST OF TABLES 
 
  PAGE 
Table 4.1 Viscosity measurement for each sample 23 
   Table 4.3.1 Summary of element in 1.5% 400 000 MW PEO + 
Protein sample 
34 
   Table 4.3.2 Summary of element in 1.5% 400 000 MW PEO + Etoh 
+ Protein sample 
35 
Table 4.1 Summary of element in 3.0% 400 000 MW PEO + 
Protein sample 
36 
 
  
x 
 
LIST OF FIGURES 
 
  PAGE 
Figure 2.1 Schematic diagram of set up of electrospinning 
apparatus (a) typical vertical set up and (b)  
horizontal set up of electrospinning apparatus 
10 
Figure 3.2 Schematic representation of different nanotechnology 
based drug delivery systems 
14 
Figure 3.4 Electrospinning machine set up 21 
Figure 3.7 The summary of workflow 22 
Figure 4.1 Graph of Viscosity over samples 24 
     Figure 4.2.1a 1.5 % w/v 400 00 MW PEO under 5000 
magnification 
25 
     Figure 4.2.1b 1.5 % w/v 400 00 MW PEO under 20 000   
 magnification 
25 
     Figure 4.2.1c 1.5 % w/v 900 00 MW PEO under 5000   
magnification 
26 
     Figure 4.2.1d 1.5 % w/v 900 00 MW PEO under 20 000  
magnification 
26 
     Figure 4.2.2a 1.5% PEO 400K + Ethanol under 5000    
magnification 
28 
    Figure 4.2.2b 1.5% PEO 400K + Ethanol under 20 000    
magnification 
28 
    Figure 4.2.2c 1.5% PEO 900K + Ethanol under 5000    
magnification 
29 
     Figure 4.2.2d 1.5% PEO 900K + Ethanol under 20 000 
magnification 
29 
    Figure 4.2.2e 1.5% PEO 400K + Protein under 5000   
magnification 
30 
   Figure 4.2.2f 1.5% PEO 400K + Protein under 20 000   30 
xi 
 
 magnification 
    Figure 4.2.2g 3.0% PEO 400K + Protein under 5000    
magnification 
31 
    Figure 4.2.2h 3.0% PEO 400K + Protein under 20 000    
magnification 
31 
    Figure 4.2.2i 1.5% PEO 400K + Protein + Ethanol under 5000    
magnification 
32 
   Figure 4.2.2j 1.5% PEO 400K + Protein + Ethanol under 20 000    
magnification 
32 
  Figure 4.3.1 EDX Spectrum of the component in 1.5% 400 000  
MW PEO + Protein  
34 
  Figure 4.3.2 EDX Spectrum of the component in 1.5% 400 000   
MW PEO + Etoh + Protein  
35 
  Figure 4.3.3 EDX Spectrum of the component in 3.0% 400 000   36 
MW PEO + Protein  
36 
Figure A.1 Polyethylene Oxide 43 
Figure A.2 Solution prepared 43 
Figure A.3 Solution was stirred overnight 44 
Figure A.4 Insertion of syringe into electrospinning machine 44 
Figure A.5 Electrospinning parameter set up 45 
Figure A.6 Electrospinning machine 45 
Figure B.1 Field Emission Scanning Electron Microscope 46 
Figure C.1 Energy Dispersive X-Ray 47 
 
 
 
 
 
 
 
xii 
 
LIST OF ABBREVIATIONS 
 
C    Carbon 
DC   Direct Current 
DDS   Drug Delivery System 
EDX   Energy Dispersion X-Ray 
Etc   Et cetera 
Etoh   Ethanol 
FE-SEM  Field Emission Scanning Electron Microscope 
K   Potassium 
MW   Molecular Weight 
Na   Sodium 
NPs   Nanoparticles 
PEO   Polyethylene 
S   Sulphur 
Si   Silicone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiii 
 
LIST OF SYMBOLS 
 
%   Percentage 
Μ   Micro 
G   Gauge 
h   hour 
k   kilo 
m   Meter 
ml   mililiter 
mm   millimeter 
MPa   Mega Pascal 
Nm   Nanometer 
RPM   Revolution Per Minutes 
s   second 
S   Siemens (unit of conductivity) 
V   Voltage 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
 
 
 
 
CHAPTER 1 
 
 
INTRODUCTION 
 
 
1.1 Background of Study 
 
Cancer is a disease in which the control of growth is lost in one or more cells, 
leading   either to a solid mass of cells known as a tumour or to a liquid cancer .It is 
one of the leading causes of death throughout the world, in which the main 
treatments involve surgery, chemotherapy, and radiotherapy (Nussbaumer et 
al.,2011). Nanotechnology, which deals with features as small as a 1 billionth of a 
meter, began to enter into mainstream physical sciences and engineering some 20 
years ago. Lamprecht (2009) describes the use of nanoparticulate drug delivery 
systems as one important aspect in the newly developing field of nanomedicine to 
allow innovative therapeutic approaches.  
Nanotechnology as a delivery device has a very promising application in drug 
delivery as it has advantages to enhance drug transport across biological barriers and 
deliver the drug at selective or targeted tissue or organ. As the principle of drug 
targeted is to reduce the total amount of drug administration, ongoing efforts have 
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been made over the past decade to develop systems or drug carriers that are capable 
of delivering the active molecules specifically to the target organs to increase the 
therapeutic efficacy. The site-specific delivery systems will allow an effective drug 
concentration to be maintained for a longer time interval and decrease the side 
effects. Recent applications of nanoscience include the use of nanoscale materials in 
electronics, catalysis, and biomedical research. Among these applications, strong 
interest has been shown to biological processes such as blood coagulation control 
and multimodal bioimaging, which has brought about a new and exciting research 
field called nanobiotechnology (Suh et al., 2009).  
Nanoparticulate delivery systems are extensively investigated as a drug 
delivery strategy in the pharmaceutical research. In general, nanocarriers may protect 
a drug from degradation, enhance drug absorption by facilitating diffusion through 
epithelium, modify pharmacokinetic and drug tissue distribution profile and improve 
intracellular penetration and distribution (Elzoghby et al., 2012). Nanoparticles 
provide a new mode of cancer drug delivery functioning as a carrier for entry 
through fenestrations in tumour vasculature allowing direct cell access. Different 
types of nano-sized carriers, such as polymeric nanoparticles, solid lipid 
nanoparticles, ceramic nanoparticles, magnetic nanoparticles, polymericmicelles, 
polymer-drug conjugates, nanotubes, nanowires, nanocages and dendrimers, are 
being developed for various drug-delivery applications  
Polymeric nanoparticles can be fabricated from polysaccharides proteins and 
synthetic polymers (Elzoghby et al., 2012). Among the available potential colloidal 
drug carrier systems, protein-based nanoparticles are particularly interesting as they 
hold certain advantages such as greater stability during storage and in vivo, being 
non-toxic and non-antigenic and their ease to scale up during manufacture over other 
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drug delivery systems (Elzoghby et al., 2012). The efficiency of drug delivery to 
various parts of the body is directly affected by particle size. Nanostructure mediated 
drug delivery, a key technology for the realization of nanomedicine, has the potential 
to enhance drug bioavailability, improve the timed release of drug molecules, and 
enable precision drug targeting (Hughes, 2005).  
Electrospinning is a technique that can easily fabricate nanofiber, nanobeads 
and microfiber meshes from different types of polymer. Due to their unique features 
such as high surface-to-volume ratio, morphological design flexibility and 
extracellular matrices structure-like, nanoparticles are used as scaffolds for drug 
delivery and tissue engineering. Low molecular weight drugs and biomolecules such 
as proteins and nucleic acids can be encapsulated into the electrospun fibers (Xu et 
al., 2008). 
 
 
1.2 Problem Statement 
 
Most of the drugs used nowadays give side effect to patient due to toxicity 
and lack of therapeutic ethic. Moreover, the efficiency toward cancer cell also is still 
in lower form. Henceforth, in order to solve this problem, the used of 
nanotechnology have become more important for cancer treatment. According to 
Kim and Pack (2006), a wide variety of new, more potent and specific therapeutics 
are being created in advances in biotechnology. A drug delivery system is designed 
to provide a therapeutic agent in the needed amount, at the right time and to the 
proper location in the body in a manner that optimizes the efficacy, increases 
compliance and minimizes side effects. Due to common problems in drug delivery 
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such as low solubility, high potency and poor stability, it can impact the efficiency 
and potential of the drug itself. Thus, there is a corresponding need for safer and 
more effective methods and devices for drug delivery.  
Biodegradable nanoparticles are frequently used to improve the therapeutic 
value, improving bioavailability, solubility, and retention time. It also helps to 
reduces expenses for the treatment and risk of toxicity. 
 
 
1.3 Objectives 
 
1.3.1 To study the effect of PEO of different molecular weight toward the formation 
of nanobeads. 
1.3.2 To study the effect of solution viscosity on the nanobeads formation. 
 
 
1.4 Scope of Study 
 
1.4.1 To study the effect of different molecular weight of Polyethylene Oxide (PEO)    
on nanobeads formation. 
1.4.2 To study the effect on nanobeads formation by using different concentration of 
PEO that will affect the viscosity 
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1.5 Rationale of Significant Study 
 
The significance of this research is to identify the formation of nanoparticles 
using electrospinning of different concentration and viscosity of solution. By using 
nanobaeads membrane encapsulated with drug as device, the drug can be released at 
controlled rates for a long period of time. The advantages of employing such systems 
are the drug release rates can be designed to the needs of a specific application. Apart 
from that, controlled drug delivery systems may provide drug protections especially 
proteins that are easily destroyed by the body. Controlled drug delivery systems can 
also increase patient comfort and compliance by substituting frequent doses (daily 
injectibles) with infrequent injection (once a month injection or less). 
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CHAPTER 2 
 
 
LITERATURE REVIEW 
 
 
2.1 Electrospinning 
 
2.1.1 History of Electrospinning 
 
 Elcetrospinning is a technique that used very high voltage power supply to 
produce nanofibers. It also used to produce nanobeads using certain variation in 
parameter. According to Liang et al., (2007), the word electrospinning is derived 
from electrostatic spinning. This technique has been used recently since 1994. 
However, Liang et al., (2007) stated that electrospinning was first observed in 1897 
by Rayleigh.  
 The popularity of this technique can be approved by the statistic and fact that 
over 200 universities and research institutes from around the world are studying 
electrospinning as claimed by Zussman et al., (2003). There are various aspects of 
the electrospinning process and the fiber it produces and also the number of patents 
for applications based on electrospinning has grown in recent years. Some companies 
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such as eSpin Technologies, NanoTechnics, and KATO Tech are actively engaged in 
reaping the benefits of the unique advantages offered by electrospinning. Meanwhile, 
companies such as Donaldson Company and Freudenberg have been using this 
process for the last two decades in their air filtration products (Ramakrishna et al., 
2006). 
 This electrospinning is broadly used technology for electrostatic fiber 
formation which uses electrical forces to produce electropun fibers with diameters 
ranging from 2nm to several micrometers. It uses polymer solutions of both natural 
and synthetic polymers. This technique seems to be increasingly applied in research 
and had take the commercial attention over the past decade according to Ahn et al., 
(2006).As claimed by Zussman et al., (2003), this process offers unique capabilities 
and advantages for producing novel natural nanofibers and fabrics with controllable 
pore structure. 
 According to Reneker et al., (2000) this process of electrospinning has gained 
a lot of attention over the world. This phenomenon in the last decade not only due to 
its versatility in spinning a wide variety of polymeric fibers, but also  its capability in 
producing consistent fibers and nanobeads in the submicron range consistently.This 
consistency is otherwise difficult to achieve by using standard mechanical  fiber-
spinning technologies techniques (Reneker et al.,2000). According to Luu et al., 
(2003), electrospun fibers have been successfully applied in various fields, such as, 
nanocatalysis, tissue engineering scaffolds, protective clothing, filtration, biomedical, 
pharmaceutical, optical electronics, healthcare, biotechnology, defense and security, 
and environmental engineering because of the smaller pores and higher surface area 
than regular beads. 
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 Overally, this electrospinning is relatively simple and effective to produce 
nanobeads from a variety of polymers. Although it is more suitable to produce 
nanofiber, but nanobeads formation are also possible using electrospinning as 
claimed bt Liang et al., (2007). Spun nanobeads also offer some advantages such as 
high surface-to-volume ratio, tunable porosity, malleability to conform to a wide 
variety of sizes and shapes (Liang et al., 2007). Hence forth, Liang et al., (2007) also 
claimed that because of these advantages, electrospun nanofibers have been widely 
investigated in the past several years. Those advantages are probably had been 
applied to several process such as filtration, optical and chemical sensors, electrode 
materials and biological scaffolds (Liang et al., 2007). 
 
 
2.1.2 Electrospinning Process 
 
 Electrospinning , a spinning technique that used unique approach that is by 
using electrostatic forces to produce fine electrospun from polymer solutions. The 
electrospun produced have a thinner diameter (from nanometer to micrometer) as 
stated by Kidoaki et al., (2005). Moreover, a very high voltage supply a range of 
several tens of kVs is necessary for the process. According to Chew et al., ( 2006a), 
various techniques such as electrostatic precipitators and pesticide sprayers work 
similarly to the electrospinning process and this process, mainly based on the 
principle that strong mutual electrical repulsive forces overcome weaker forces of 
surface tension in the charged polymer liquid. Based on the Kidoaki et al., (2005), 
there are two types of electrospinning that had been used nowadays. The two types of 
electrospinning are vertical and horizontal. With the expansion of this technology, 
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several research groups have developed more sophisticated systems that can fabricate 
more complex nanofibrous structures in a more controlled and efficient manner. 
This process of electrospinning should be running at room temperature with 
standard atmosphere conditions. The standard set up of electrospinning apparatus is 
shown in Figure 2.1 (a and b). The standard electrospinning process consists of three 
major components that are a high voltage power supply, a spinneret and a grounded 
collecting plate and utilizes a high voltage source to inject charge of a certain 
polarity into a polymer solution or melt, which is then accelerated towards a collector 
of opposite polarity (Liang et al., 2007). 
According to the article from Huang et al., (2003), they claimed that most of 
the polymers are dissolved in some solvents before electrospinning, and when it 
completely dissolves forms polymer solution. The polymer fluid is then introduced 
into the capillary tube for electrospinning. However, Huang et al., (2003) also 
claimed that some polymers may emit unpleasant or even harmful smells, so the 
processes should be conducted within chambers having a ventilation system. In the 
electrospinning process, a polymer solution held by its surface tension at the end of a 
capillary tube is subjected to an electric field and an electric charge is induced on the 
liquid surface due to this electric field. When the electric field applied reaches a 
critical value, the repulsive electrical forces overcome the surface tension forces. 
Eventually, a charged jet of the solution is ejected from the tip of the Taylor 
cone and an unstable and a rapid whipping of the jet occurs in the space between the 
capillary tip and collector which leads to evaporation of the solvent, leaving a 
polymer behind (Milasius, 2007). The jet is only stable at the tip of the spinneret and 
after that instability starts. Thus, the electrospinning process offers a simplified 
technique for fiber formation. 
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Figure 2.1 Schematic diagram of set up of electrospinning apparatus (a) typical 
vertical set up and (b) horizontal set up of electrospinning apparatus. (Source: Parven 
et al, 2012) 
 
 
 
 
a) 
b) 
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2.2 Drug Delivery Technology 
 
Researches on drug delivery system (DDS) have many benefits on 
pharmaceutical industry nowadays. According to Swatantra et al., (2012), some of 
the benefits are include improved therapy by increasing the efficacy and duration of 
drug activity, increased patient compliance through decreased dosing frequency and 
convenient routes of administration and improved targeting for a specific site to 
reduce unwanted side effects. Those researches also state about the challenge for 
both drug and drug delivery companies is to deliver both existing and emerging drug 
technologies in a manner that improves the benefits to the patients. 
Over the past several years, great advances have been made on development 
of novel drug delivery systems of anticancer drug. According to Ajazuddin et al., 
(2010), in phyto-formulation research, developing nanodosage have a number of 
advantages for herbal drugs, including enhancement of solubility and bioavailability, 
protection from  toxicity, enhancement of pharmacological activity, enhancement of 
stability, improving tissue macrophages distribution, sustained delivery, protection 
from physical and chemical degradation. Some of the examples for the nanodosage 
polymeric are nanoparticles and nanocapsules, liposomes, solid lipid nanoparticles, 
phytosomes and nanoemulsion (Ajazuddin et al., 2010). 
Injectable polymers that have biocompatibility and biodegradability are 
important biomaterials for drug delivery system (DDS) and tissue engineering 
(Swatantra et al., 2012). Accoring to Medina et al., (2004), multiple synthetic and 
natural biodegradable polymers have been investigated for these purposes, including 
polyesters, polyethers, poly amino-acids, polysaccharides, and proteins. These 
polymers are employed as injectable drug delivery system, and especially as 
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injectable drug delivery system for cancer chemotherapy, and have been investigated 
actively so as to minimize the toxic side effects and increase the carcinostatic 
pharmaceutical effects (Heller et al., 2004). Methods of local administration of drug 
delivery system, nanoparticles, microspheres, polymeric micelles, liposomes, and 
hydrogel systems, for targeting and controlled release have been investigated with 
nonand biodegradable polymers. However, the targeting drug delivery system has 
not been satisfactorily achieved. 
 
 
2.3 Nanoparticles in Drug Delivery 
   
Drug delivery is an interdisciplinary and independent field of research and is 
gaining the attention of pharmaceutical researchers, medical doctors and industry as 
stated by Singh et al., (2009). A safe and targeted drug delivery could improve the 
performance of some classic medicines already on the market, and moreover, will 
have implications for the development and success of new therapeutic strategies such 
as anticancer drug delivery, peptide and protein delivery and gene therapy. 
According to Parveen et al., (2012) several drug-delivery technologies have emerged 
and a fascinating part of this field is the development of nanoscale drug delivery 
devices in the last decade.  
Nanoparticles (NPs) have been developed as an important strategy to deliver 
conventional drugs, recombinant proteins, vaccines and more recently, nucleotides. 
NPs and other colloidal drug-delivery systems modify the kinetics, body distribution 
and drug release of an associated drug. This review article focuses on the potential of 
nanotechnology in medicine and discusses different nanoparticulate drug-delivery 
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systems including polymeric NPs, ceramic NPs, magnetic NPs, polymeric micelles 
and dendrimers as well as their applications in therapeutics, diagnostics and imaging 
(Parveen et al., 2012). The applications of nanotechnology in various disciplines and 
specifically in healthcare are becoming increasingly common and the process of 
replacing traditional medicines has already begun. Thus, although efficient drug 
delivery is one of the most prominent problems faced by the biotechnological and 
pharmaceutical industries, nanotechnology can promote the innovative utilization of 
the myriad existing drugs produced by these industries. 
Nanotechnology focuses on formulating therapeutic agents in biocompatible 
nanocarriers, such as NPs, nanocapsules, micellar systems and dendrimers (Figure 
2.2). Moreover, one of the major advantages that nanotechnology offers is targeted 
drug delivery to the site of disease. This can be achieved either through passive 
targeting of drugs to the site of action or by active targeting of the drug (Parveen et 
al., 2012) 
 
 
 
 
 
 
 
 
 
 
 
